Immunotherapy for Blood Disorders
About the procedure
Immunotherapy harnesses the body’s immune system to target abnormal blood cells in certain hematologic conditions, including leukemia and lymphoma. This advanced treatment may involve monoclonal antibodies or immune-modulating agents designed to specifically attack diseased cells while preserving healthy tissue. Immunotherapy offers a targeted approach that can improve outcomes and reduce some side effects compared to traditional therapies.
Care Before the Procedure
- Disease evaluation and staging
- Laboratory and imaging review
- Treatment eligibility assessment
- Patient counseling
Care During the Procedure
- Administration of immunotherapy agents
- Monitoring for infusion reactions
- Regular laboratory monitoring
- Symptom assessment
Care After the Procedure
- Follow-up visits
- Monitoring immune response
- Side effect management
- Long-term disease surveillance
Eligibility
- Certain leukemia patients
- Lymphoma cases
- Relapsed hematologic cancers
- Patients eligible for targeted immune therapy





